Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
19 studies found for:    "Primary hyperoxaluria type 1"
Show Display Options
Rank Status Study
1 Recruiting A Study of DCR-PH1 in Patients With Primary Hyperoxaluria Type 1 (PH1)
Condition: Primary Hyperoxaluria Type 1
Intervention: Drug: DCR-PH1
2 Recruiting Study of ALN-GO1 in Healthy Adult Subjects and Patients With Primary Hyperoxaluria Type 1
Condition: Primary Hyperoxaluria Type 1 (PH1)
Interventions: Drug: ALN-GO1;   Drug: Sterile Normal Saline (0.9% NaCl)
3 Completed Primary Hyperoxaluria Mutation Genotyping
Condition: Primary Hyperoxaluria
Intervention: Genetic: Genetic Analysis
4 Recruiting Primary Hyperoxaluria Mutation Genotyping/Phenotyping
Condition: Primary Hyperoxaluria
Intervention: Other: Genetic Analysis
5 Completed Trial on Treatment of Patients With Primary Hyperoxaluria Type I With Pyridoxal-phosphate
Condition: Primary Hyperoxaluria Type I
Intervention: Drug: Vitamin B 6
6 Completed IDENTIFICATION OF A MULTI-ANALYTE PROFILE FOR PRIMARY HYPEROXALURIA AND COMPARISON WITH HEALTHY SIBLINGS AND IDIOPATHIC HYPERCALCIURIA
Conditions: Primary Hyperoxaluria Type 1;   Idiopathic Hypercalciuria
Interventions: Other: Urines samples;   Other: Blood sample
7 Completed Study to Evaluate the Efficacy and Safety of Oxabact (OC5) in Patients With Primary Hyperoxaluria
Condition: Primary Hyperoxaluria
Interventions: Biological: Oxabact OC5 capsules;   Drug: Placebo capsules
8 Recruiting Study to Evaluate the Efficacy and Safety of Oxabact (OC5) in Primary Hyperoxaluria Patients Who Are on Dialysis
Condition: Primary Hyperoxaluria
Intervention: Biological: Oxalobacter formigenes
9 Completed Study to Evaluate the Efficacy and Safety of OxabactTM on Reduction of Urinary Oxalate in Primary Hyperoxaluria Patients
Condition: Primary Hyperoxaluria
Interventions: Biological: Oxalobacter formigenes;   Drug: Placebo
10 Withdrawn International Registry for Primary Hyperoxaluria
Conditions: Primary Hyperoxaluria;   Nephrocalcinosis;   Kidney Stones
Intervention:
11 Recruiting Rare Kidney Stone Consortium Biobank
Conditions: Primary Hyperoxaluria;   Dent Disease;   APRT Deficiency;   Cystinuria
Intervention:
12 Completed Phase 2/3 Oxabact Study
Condition: Primary Hyperoxaluria
Interventions: Biological: Oxalobacter formigenes;   Drug: Placebo
13 Recruiting Rare Kidney Stone Consortium Patient Registry
Conditions: Primary Hyperoxaluria;   Dent Disease;   Cystinuria;   APRT Deficiency
Intervention:
14 Withdrawn Renal Protective Effect of ACEI and ARB in Primary Hyperoxaluria
Condition: Hyperoxaluria
Interventions: Drug: ACEI / Angiotensin converting enzyme inhibitor;   Drug: ARB /Angiotensin Receptor Blocker;   Drug: Placebo
15 Completed
Has Results
Efficacy of Betaine for Reduction of Urine Oxalate in Patients With Type 1 Primary Hyperoxaluria
Condition: Hyperoxaluria
Interventions: Drug: Betaine;   Drug: Placebo
16 Recruiting Health-related Quality of Life in Rare Kidney Stone
Conditions: Primary Hyperoxaluria;   Cystinuria;   Adenine Phosphoribosyl Transferase Deficiency;   Dent Disease
Intervention: Other: Health-related Quality of Life in Rare Kidney Stone Wuestionnaire
17 Not yet recruiting Descriptive Analysis of Gut Microbiome Alterations in Hyperoxaluric Patients
Condition: Oxalate, Primary Hyperoxaluria, Microbiome
Intervention:
18 Recruiting Prospective Research Rare Kidney Stones (ProRKS)
Conditions: Hyperoxaluria;   Cystinuria;   Dent Disease;   Lowe Syndrome;   Adenine Phosphoribosyltransferase Deficiency
Intervention:
19 Active, not recruiting Hydroxyproline Influence on Oxalate Metabolism
Condition: Hyperoxaluria
Intervention: Drug: Hydroxyproline and Leucine

Indicates status has not been verified in more than two years